<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1960">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03081364</url>
  </required_header>
  <id_info>
    <org_study_id>15-335</org_study_id>
    <nct_id>NCT03081364</nct_id>
  </id_info>
  <brief_title>Patient Registry Of Magnetic Resonance Imaging in Non-Approved DEvices</brief_title>
  <acronym>PROMeNADe</acronym>
  <official_title>Patient Registry Of Magnetic Resonance Imaging in Non-Approved DEvices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Luke's Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Luke's Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are providing MRI in patients with non-MRI approved CIED's (Cardiac
      Implanted Electronic Devices)
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Change in Device Function</measure>
    <time_frame>3 years</time_frame>
    <description>Change in lead impedance or sensing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Thresholds of Pacing Lead</measure>
    <time_frame>3 years</time_frame>
    <description>Measured in mA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dysrhythmias Noted During Scan</measure>
    <time_frame>3 years</time_frame>
    <description>Change in heart rhythm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen Saturation</measure>
    <time_frame>3 years</time_frame>
    <description>Percentage of change or no change</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Vital Signs</measure>
    <time_frame>3 years</time_frame>
    <description>Measured in heart rate and blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Comments</measure>
    <time_frame>3 years</time_frame>
    <description>What sensations, if any, are reported by the patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interference Between the Implanted Cardiac Electronic Device and MRI</measure>
    <time_frame>3 years</time_frame>
    <description>Measure any change in device battery voltage</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Magnetic Field Exposure</condition>
  <arm_group>
    <arm_group_label>Outpatients</arm_group_label>
    <description>MRI; Critical Care Monitoring, Device Programming</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Initiate ACLS protocol if lethal arrythmia develops</intervention_name>
    <description>Cardiac Rhythm Management</description>
    <arm_group_label>Outpatients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        For all patients in whom a clinical MRI examination is felt to be important in the
        patients care, and in whom the potential benefits clearly outweigh the risks of an MRI
        exam as referred from various primary and/or subspecialty physicians.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Anyone with a cardiac device

        Exclusion Criteria:

          -  Anyone who cannot consent for themselves or who don't have a durable power of
             attorney
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim M Saeed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Luke's Hospital of Kansas City</affiliation>
  </overall_official>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 10, 2017</lastchanged_date>
  <firstreceived_date>January 4, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Implanted Device</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share the IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
